Search

Your search keyword '"Kaiser, Ulrich"' showing total 773 results

Search Constraints

Start Over You searched for: Author "Kaiser, Ulrich" Remove constraint Author: "Kaiser, Ulrich"
773 results on '"Kaiser, Ulrich"'

Search Results

9. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries

10. Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia

11. Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial

12. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia

13. The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany

14. Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience

15. Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

16. Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

17. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome

18. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome

19. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

23. " I can't do it anymore": a qualitative study on the emergence of crisis in outpatient palliative care—the perspective of family caregivers.

24. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

25. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome

26. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

31. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

32. Initial experiences with dynamic, quality indicator-based multimodal tissue analysis (M-Ref) with parallel assessment of viscosity and shear wave elastography in liver parenchyma alterations1.

33. Handheld ultrasound for portal vein evaluation in pediatric patients.

34. Use of a handheld system for interventional ultrasound with puncture and biopsy in an in vitro liver model.

37. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

39. The WERA Cancer Center Matrix: Strategic Management of Patient Access to Precision Oncology in a Large and Mostly Rural Area of Germany

41. No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens

42. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

47. Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial

48. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

49. Wireless handheld ultrasound for internal jugular vein assessment in pediatric patients.

Catalog

Books, media, physical & digital resources